Compare StocksABBV vs VTR

AbbVie Inc. (ABBV) vs Ventas, Inc. (VTR): Which Is the Better Buy in 2026?

As of 2026-06-19, ABBV is overvalued at $216, with a DCF intrinsic value of $160 and a margin of safety of -35%. VTR is undervalued at $82, with an intrinsic value of $133 and a margin of safety of 39%. Of the two, VTR has the wider margin of safety.

ABBV
AbbVie Inc.
$216.49
VS
VTR
Ventas, Inc.
$81.60

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
VTR
  • Free cash flow has grown at a 14.6% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • FCF yield of 5.4% suggests reasonable valuation assuming continued moderate growth.
  • Trailing P/E of 105.6x is 69% above the historical average of 62.3x — the stock trades at a premium to its own history.
VTR
  • Share count has increased by 19% over the past 4 years, diluting existing shareholders.
  • Net debt/EBITDA of 5.5x indicates heavy leverage — it would take over 4 years of EBITDA to pay off net debt.
  • Altman Z-Score of 1.78 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.

Key Valuation Metrics

Learn more →
ABBV
VTR
Valuation
$20.81B
Free Cash Flow
$1.48B
5.44%
FCF Yield
3.74%
105.60
Trailing P/E
148.36
13.32
Forward P/E
96.38
Quality & Moat
21.89%
ROIC
2.53%
N/A
ROE
2.14%
72.03%
Gross Margin
40.49%
0.61
PEG Ratio
1.72
Balance Sheet Safety
N/A
Net Debt / Equity
0.92
N/A
Interest Coverage
N/A
2.12
Net Debt / EBITDA
5.48
3.11%
Dividend Yield
2.38%
ABBV: 9Ties: 1VTR: 0
ABBVVTR

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

VTR

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
VTR
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-2.03B
Δ Market Cap
+$18.74B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
35.3% Overvalued
Price is 35.3% above estimated fair value
Current Price: $216.49
Fair Value: $160.05
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
VTR
38.8% Margin of Safety
Price is 38.8% below estimated fair value
Current Price: $81.60
Fair Value: $133.28
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

What growth rate is the market pricing in at $216?

+17.1%
Market-Implied Owner Earnings Growth
Standard FCF implies +8.7%

The market implies +17.1% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +8.7%, reflecting heavy growth investment.

VTR

What growth rate is the market pricing in at $82?

+20.6%
Market-Implied Owner Earnings Growth
Standard FCF implies +15.4%

The market implies +20.6% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +15.4%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
VTR
49/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with revenue predictability as the key competitive advantage. Improving roic consistency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
VTR
-2.45
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone
Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.9%Retail & Other 23.0%
No. of Institutional Holders5,106
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
VTR
Insiders 0.5%Institutions 107.0%
No. of Institutional Holders1,364
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
VTR
1
Buys (3M)
1
Buys (12M)
Total value (12M): $197,025
EMBLER MICHAEL J
Director
$197,025
@ $78.81 · 2026-06-03
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
0
Sells (3M)
5
Sells (12M)
Total value (12M): $21.79M
PURDUE DAVID R.
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
GONZALEZ RICHARD A
Officer and Director
$12.40M
@ $186.52 · 2024-08-05
GONZALEZ RICHARD A
Officer and Director
$49.50M
@ $175.00 · 2024-07-17
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
VTR
1
Sells (3M)
27
Sells (12M)
Total value (12M): $77.75M
RAKOWICH WALTER C.
Director
$103,915
@ $90.20 · 2026-05-14
ROBERTS CAREY SHEA
General Counsel
$3.02M
@ $85.00 · 2026-02-11
CAFARO DEBRA A
Chief Executive Officer
$848,751
@ $82.23 · 2026-02-06
CAFARO DEBRA A
Chief Executive Officer
$801,605
@ $77.66 · 2026-02-02
PROBST ROBERT F.
Chief Financial Officer
$2.31M
@ $77.25 · 2026-01-02
CAFARO DEBRA A
Chief Executive Officer
$797,475
@ $77.26 · 2026-01-02
CAFARO DEBRA A
Chief Executive Officer
$831,419
@ $80.55 · 2025-12-01
BULGARELLI PETER J
Officer
$400,205
@ $80.04 · 2025-11-19
CAFARO DEBRA A
Chief Executive Officer
$3.26M
@ $79.01 · 2025-11-17
PROBST ROBERT F.
Chief Financial Officer
$2.58M
@ $76.77 · 2025-11-12
BULGARELLI PETER J
Officer
$3,028
@ $75.70 · 2025-11-07
BULGARELLI PETER J
Officer
$372,256
@ $75.05 · 2025-11-06
CAFARO DEBRA A
Chief Executive Officer
$2.33M
@ $75.19 · 2025-11-06
CAFARO DEBRA A
Chief Executive Officer
$25.08M
@ $74.22 · 2025-11-03
CAFARO DEBRA A
Chief Executive Officer
$15.66M
@ $71.32 · 2025-10-20
BULGARELLI PETER J
Officer
$322,215
@ $70.14 · 2025-10-01
CAFARO DEBRA A
Chief Executive Officer
$724,986
@ $70.24 · 2025-10-01
BULGARELLI PETER J
Officer
$28,419
@ $70.00 · 2025-09-15
CAFARO DEBRA A
Chief Executive Officer
$699,864
@ $67.80 · 2025-09-02
PROBST ROBERT F.
Chief Financial Officer
$2.03M
@ $68.49 · 2025-08-04
CAFARO DEBRA A
Chief Executive Officer
$695,722
@ $67.40 · 2025-08-01
PROBST ROBERT F.
Chief Financial Officer
$266,960
@ $68.45 · 2025-07-31
PROBST ROBERT F.
Chief Financial Officer
$1.95M
@ $66.29 · 2025-07-21
PROBST ROBERT F.
Chief Financial Officer
$271,454
@ $66.24 · 2025-07-18
CAFARO DEBRA A
Chief Executive Officer
$287,976
@ $65.82 · 2025-07-18
CAFARO DEBRA A
Chief Executive Officer
$1.07M
@ $65.60 · 2025-07-16
PROBST ROBERT F.
Chief Financial Officer
$11.00M
@ $65.36 · 2025-07-14
ROBERTS CAREY SHEA
General Counsel
$1.51M
@ $64.23 · 2025-05-30
PROBST ROBERT F.
Chief Financial Officer
$1.13M
@ $65.22 · 2025-05-27
PROBST ROBERT F.
Chief Financial Officer
$4.50M
@ $64.59 · 2025-05-21
RAKOWICH WALTER C.
Director
$93,026
@ $63.76 · 2025-05-14
CAFARO DEBRA A
Chief Executive Officer
$682,135
@ $66.09 · 2025-05-02
CAFARO DEBRA A
Chief Executive Officer
$3.17M
@ $71.06 · 2025-04-03
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😐Neutral(56/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
VTR
FearGreed
😐Neutral(53/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (56)
VTR
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (53)
View ABBV Full AnalysisView VTR Full Analysis

Frequently Asked Questions: ABBV vs VTR

Is AbbVie Inc. or Ventas, Inc. more undervalued in 2026?

Based on our discounted cash flow model, VTR trades at a 38.8% margin of safety (intrinsic value $133 vs. price $82), compared to ABBV's -35.3% margin of safety (intrinsic $160 vs. $216).

Which stock has a wider economic moat, AbbVie Inc. or Ventas, Inc.?

ABBV scores 82/100 (Wide moat), while VTR scores 49/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Ventas, Inc. in financial distress?

VTR's Altman Z-Score of 1.8 places it in the Distress zone, signaling elevated bankruptcy risk. ABBV scores 2.4 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, AbbVie Inc. or Ventas, Inc.?

AbbVie Inc. (ABBV) generates a 5.4% free cash flow yield, compared to Ventas, Inc.'s 3.7%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, AbbVie Inc. or Ventas, Inc.?

ABBV earns 21.9% ROIC versus VTR's 2.5%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or Ventas, Inc.'s?

ABBV's dividend earns a safety score of 39/100 (Unsafe), compared to VTR's 18/100 (Unsafe). ABBV has raised its dividend for 3 consecutive years.

ABBV vs VTR: Which Is the Better Buy in 2026? | SafetyMargin.io